Thomas von Erlach

Company: Vivtex

Job title: Co-Founder & Chief Scientific Officer

Seminars:

Exploring Vivtex’s Robotic Screening Platform for Optimizing the Delivery of Oral Peptides 12:00 pm

• Background behind Vivtex’s approach to developing orally administered peptides with high GI absorption • Understanding the scientific rationale underlying Vivtex’s GI Tract-Tissue Robotic Interface System (GI-TRIS) • Case studies detailing the use of this screening system to facilitate oral peptide deliveryRead more

day: Conference Day 1